Status:
UNKNOWN
Risk Factors of Intermediate Coronary Lesion Progression
Lead Sponsor:
China National Center for Cardiovascular Diseases
Conditions:
Coronary Atheroscleroses
Coronary Angiography
Eligibility:
All Genders
18+ years
Brief Summary
Coronary intermediate lesions generally refer to lumen narrowing with diameter stenosis% (DS%) between 50% and 70% on angiography. Prognosis varies significantly among patients with intermediate lesio...
Detailed Description
Study setting This ongoing study is conducted in Fuwai Hospital, one of the world's biggest cardiovascular center specializing in all kinds of cardiovascular diseases, particularly those complex, diff...
Eligibility Criteria
Inclusion
- Receiving elective coronary angiography
- Written informed consent
- One or more lesions located in main coronary arteries with intermediate stenosis (defined as diameter stenosis of 50%-70%)
- No lesions with significant stenosis (greater than 70%)
Exclusion
- Unable to sign consent
- Receiving percutaneous coronary intervention (PCI) or coronary artery bypass graft (CABG)
- Planned PCI or CABG
- Left ventricle ejection fraction % (LVEF%)\<35% or cardiogenic shock
- Other severe comorbidities with life expectancy \<1 year
Key Trial Info
Start Date :
January 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2020
Estimated Enrollment :
1389 Patients enrolled
Trial Details
Trial ID
NCT03855436
Start Date
January 1 2017
End Date
December 1 2020
Last Update
February 26 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fuwai Hospital
Beijing, Beijing Municipality, China, 100037